Table 4.
Predictors of inpatient THC in patients with AH
| Predictor | Factor (fold increase) | 95 % Confidence Interval |
|---|---|---|
| Age | 0.99 | 0.98–0.99* |
| Sex | ||
| Male | Reference | |
| Female | 1.03 | 0.94–1.15 |
| Race/Ethnicity | ||
| White | Reference | |
| Black | 1.24 | 0.96–1.60 |
| Hispanic | 1.25 | 1.01–1.49* |
| Other | 0.94 | 0.79–1.13 |
| Income | ||
| Lowest 25 % | 0.93 | 0.76–1.13 |
| 25–50 % | Reference | |
| 50–75 % | 1.07 | 0.92–1.25 |
| 75–100 % | 1.18 | 1.03–1.34* |
| Payer | ||
| Medicaid | 0.85 | 0.73–0.98* |
| Medicare | 0.94 | 0.81–1.09 |
| Private | Reference | |
| Self-pay | 0.75 | 0.62–0.91** |
| Other | 0.84 | 0.72–0.99* |
| Length of Stay | 1.02 | 1.02–1.03*** |
| Charlson Index | 1.04 | 1.02–1.07*** |
| Severity of liver disease | ||
| No cirrhosis | Reference | |
| Stage 1–2 | 1.12 | 0.97–1.31 |
| Stage 3–4 | 1.01 | 0.89–1.15 |
| Number of Procedures | ||
| 0 | Reference | |
| 1 | 1.27 | 1.20–1.34*** |
| 2 | 1.74 | 1.53–1.99*** |
| > 2 | 2.97 | 2.72–3.25*** |
| Hospital Region | ||
| Northeast | Reference | |
| Midwest | 1.06 | 0.85–1.33 |
| South | 0.88 | 0.70–1.11 |
| West | 1.32 | 1.02–1.71* |
| Teaching Hospital | ||
| No | Reference | |
| Yes | 1.10 | 0.94–1.28 |
| Hospital setting | ||
| Urban | 1.28 | 1.11–1.48*** |
| Rural | Reference | |
Parameter coefficients are presented as a fold increase with 95 % CI
Final general linear model included survey weights and the following, variables: age, sex, race/ethnicity, income, payer, length of inpatient stay, Charlson comorbidity score, severity of liver disease, hospital region, teaching hospital status, hospital location, and number of inpatient procedures
Other race refers to subjects with Asian, Pacific islander, Native American, or another race
CI confidence interval
*P <0.05; **P <0.01; ***P <0.001